Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma

Arianna Smorlesi; Francesca Papalini; Augusto Amici; Fiorenza Orlando; Sara Pierpaoli; Chiara Mancini; Mauro Provinciali

doi:10.1016/j.vaccine.2005.10.022

Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma

Arianna Smorlesi, Francesca Papalini, Augusto Amici, Fiorenza Orlando, Sara Pierpaoli, Chiara Mancini, Mauro Provinciali

Istituto Nazionale di Riposo e Cura per Anziani V.E. II

Research output: Contribution to journal › Article

Abstract

Studies of DNA vaccination against HER2/neu showed the effectiveness of immunization protocols in models of transplantable or spontaneous tumors; scarce information, however, has been provided to identify the procedure of DNA administration that more effectively contributes to the activation of immune system against spontaneously arising HER2/neu-positive tumors. We compared the effectiveness of different procedures of DNA vaccine delivery (intradermic injection (ID), gene gun (GG) delivery and intramuscular injection (IM) alone or with electroporation) in a murine transgenic model of mammary carcinoma overexpressing HER2/neu. We highlighted the role of DNA delivery system in the success of DNA vaccination showing that, among the analysed methods, intramuscular injection of the vaccine, particularly when associated to electroporation, elicits a better protection against HER2/neu spontaneous tumor development inducing antibody and cell-mediated immune responsiveness against HER2/neu and a Th1 polarization of the immune response.

Original language	English
Pages (from-to)	1766-1775
Number of pages	10
Journal	Vaccine
Volume	24
Issue number	11
DOIs	https://doi.org/10.1016/j.vaccine.2005.10.022
Publication status	Published - Mar 10 2006

Keywords

DNA delivery system
DNA vaccination
HER2/neu
Immune response
Mammary tumor

ASJC Scopus subject areas

Immunology
Microbiology
Virology
Infectious Diseases
Public Health, Environmental and Occupational Health
veterinary(all)

Access to Document

10.1016/j.vaccine.2005.10.022

Fingerprint Dive into the research topics of 'Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma'. Together they form a unique fingerprint.

Cite this

Smorlesi, A., Papalini, F., Amici, A., Orlando, F., Pierpaoli, S., Mancini, C., & Provinciali, M. (2006). Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma. Vaccine, 24(11), 1766-1775. https://doi.org/10.1016/j.vaccine.2005.10.022

Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma. / Smorlesi, Arianna; Papalini, Francesca; Amici, Augusto; Orlando, Fiorenza; Pierpaoli, Sara; Mancini, Chiara; Provinciali, Mauro.

In: Vaccine, Vol. 24, No. 11, 10.03.2006, p. 1766-1775.

Research output: Contribution to journal › Article

@article{acf6868fcba24d858a2f9e8bedc652fe,

title = "Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma",

abstract = "Studies of DNA vaccination against HER2/neu showed the effectiveness of immunization protocols in models of transplantable or spontaneous tumors; scarce information, however, has been provided to identify the procedure of DNA administration that more effectively contributes to the activation of immune system against spontaneously arising HER2/neu-positive tumors. We compared the effectiveness of different procedures of DNA vaccine delivery (intradermic injection (ID), gene gun (GG) delivery and intramuscular injection (IM) alone or with electroporation) in a murine transgenic model of mammary carcinoma overexpressing HER2/neu. We highlighted the role of DNA delivery system in the success of DNA vaccination showing that, among the analysed methods, intramuscular injection of the vaccine, particularly when associated to electroporation, elicits a better protection against HER2/neu spontaneous tumor development inducing antibody and cell-mediated immune responsiveness against HER2/neu and a Th1 polarization of the immune response.",

keywords = "DNA delivery system, DNA vaccination, HER2/neu, Immune response, Mammary tumor",

author = "Arianna Smorlesi and Francesca Papalini and Augusto Amici and Fiorenza Orlando and Sara Pierpaoli and Chiara Mancini and Mauro Provinciali",

year = "2006",

month = mar,

day = "10",

doi = "10.1016/j.vaccine.2005.10.022",

language = "English",

volume = "24",

pages = "1766--1775",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "11",

}

TY - JOUR

T1 - Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma

AU - Smorlesi, Arianna

AU - Papalini, Francesca

AU - Amici, Augusto

AU - Orlando, Fiorenza

AU - Pierpaoli, Sara

AU - Mancini, Chiara

AU - Provinciali, Mauro

PY - 2006/3/10

Y1 - 2006/3/10

N2 - Studies of DNA vaccination against HER2/neu showed the effectiveness of immunization protocols in models of transplantable or spontaneous tumors; scarce information, however, has been provided to identify the procedure of DNA administration that more effectively contributes to the activation of immune system against spontaneously arising HER2/neu-positive tumors. We compared the effectiveness of different procedures of DNA vaccine delivery (intradermic injection (ID), gene gun (GG) delivery and intramuscular injection (IM) alone or with electroporation) in a murine transgenic model of mammary carcinoma overexpressing HER2/neu. We highlighted the role of DNA delivery system in the success of DNA vaccination showing that, among the analysed methods, intramuscular injection of the vaccine, particularly when associated to electroporation, elicits a better protection against HER2/neu spontaneous tumor development inducing antibody and cell-mediated immune responsiveness against HER2/neu and a Th1 polarization of the immune response.

AB - Studies of DNA vaccination against HER2/neu showed the effectiveness of immunization protocols in models of transplantable or spontaneous tumors; scarce information, however, has been provided to identify the procedure of DNA administration that more effectively contributes to the activation of immune system against spontaneously arising HER2/neu-positive tumors. We compared the effectiveness of different procedures of DNA vaccine delivery (intradermic injection (ID), gene gun (GG) delivery and intramuscular injection (IM) alone or with electroporation) in a murine transgenic model of mammary carcinoma overexpressing HER2/neu. We highlighted the role of DNA delivery system in the success of DNA vaccination showing that, among the analysed methods, intramuscular injection of the vaccine, particularly when associated to electroporation, elicits a better protection against HER2/neu spontaneous tumor development inducing antibody and cell-mediated immune responsiveness against HER2/neu and a Th1 polarization of the immune response.

KW - DNA delivery system

KW - DNA vaccination

KW - HER2/neu

KW - Immune response

KW - Mammary tumor

UR - http://www.scopus.com/inward/record.url?scp=32544456569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32544456569&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.10.022

DO - 10.1016/j.vaccine.2005.10.022

M3 - Article

C2 - 16288939

AN - SCOPUS:32544456569

VL - 24

SP - 1766

EP - 1775

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -